These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

220 related articles for article (PubMed ID: 18684826)

  • 1. Expansion of human cytomegalovirus (HCMV) immediate-early 1-specific CD8+ T cells and control of HCMV replication after allogeneic stem cell transplantation.
    Sacre K; Nguyen S; Deback C; Carcelain G; Vernant JP; Leblond V; Autran B; Dhedin N
    J Virol; 2008 Oct; 82(20):10143-52. PubMed ID: 18684826
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Monitoring cytomegalovirus IE-1 and pp65-specific CD4+ and CD8+ T-cell responses after allogeneic stem cell transplantation may identify patients at risk for recurrent CMV reactivations.
    Gratama JW; Brooimans RA; van der Holt B; Sintnicolaas K; van Doornum G; Niesters HG; Löwenberg B; Cornelissen JJ
    Cytometry B Clin Cytom; 2008 Jul; 74(4):211-20. PubMed ID: 18454493
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Ex vivo stimulation and expansion of both CD4(+) and CD8(+) T cells from peripheral blood mononuclear cells of human cytomegalovirus-seropositive blood donors by using a soluble recombinant chimeric protein, IE1-pp65.
    Vaz-Santiago J; Lulé J; Rohrlich P; Jacquier C; Gibert N; Le Roy E; Betbeder D; Davignon JL; Davrinche C
    J Virol; 2001 Sep; 75(17):7840-7. PubMed ID: 11483727
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Identification of HLA-A*2402-restricted HCMV immediate early-1 (IE-1) epitopes as targets for CD8+ HCMV-specific cytotoxic T lymphocytes.
    Lim JB; Kim HO; Jeong SH; Ha JE; Jang S; Lee SG; Lee K; Stroncek D
    J Transl Med; 2009 Aug; 7():72. PubMed ID: 19698161
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Sensitive detection of human cytomegalovirus peptide-specific cytotoxic T-lymphocyte responses by interferon-gamma-enzyme-linked immunospot assay and flow cytometry in healthy individuals and in patients after allogeneic stem cell transplantation.
    Hebart H; Daginik S; Stevanovic S; Grigoleit U; Dobler A; Baur M; Rauser G; Sinzger C; Jahn G; Loeffler J; Kanz L; Rammensee HG; Einsele H
    Blood; 2002 May; 99(10):3830-7. PubMed ID: 11986243
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Normalizing ELISPOT responses to T-cell counts: a novel approach for quantification of HCMV-specific CD4(+) and CD8(+) T-cell responses in kidney transplant recipients.
    Calarota SA; Chiesa A; Scaramuzzi L; Adzasehoun KM; Comolli G; Mangione F; Esposito P; Baldanti F
    J Clin Virol; 2014 Sep; 61(1):65-73. PubMed ID: 24961915
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Repertoire, diversity, and differentiation of specific CD8 T cells are associated with immune protection against human cytomegalovirus disease.
    Sacre K; Carcelain G; Cassoux N; Fillet AM; Costagliola D; Vittecoq D; Salmon D; Amoura Z; Katlama C; Autran B
    J Exp Med; 2005 Jun; 201(12):1999-2010. PubMed ID: 15967826
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Human cytomegalovirus proteins pp65 and immediate early protein 1 are common targets for CD8+ T cell responses in children with congenital or postnatal human cytomegalovirus infection.
    Gibson L; Piccinini G; Lilleri D; Revello MG; Wang Z; Markel S; Diamond DJ; Luzuriaga K
    J Immunol; 2004 Feb; 172(4):2256-64. PubMed ID: 14764694
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Age-dependent association between low frequency of CD27/CD28 expression on pp65 CD8+ T cells and cytomegalovirus replication after transplantation.
    Cantisán S; Torre-Cisneros J; Lara R; Rodríguez-Benot A; Santos F; Gutiérrez-Aroca J; Gayoso I; González-Padilla M; Casal M; Rivero A; Solana R
    Clin Vaccine Immunol; 2009 Oct; 16(10):1429-38. PubMed ID: 19656991
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Inconsistent responses of cytomegalovirus-specific T cells to pp65 and IE-1 versus infected dendritic cells in organ transplant recipients.
    Lilleri D; Zelini P; Fornara C; Comolli G; Gerna G
    Am J Transplant; 2007 Aug; 7(8):1997-2005. PubMed ID: 17617865
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Functional patterns of cytomegalovirus (CMV) pp65 and immediate early-1-specific CD8(+) T cells that are associated with protection from and control of CMV DNAemia after allogeneic stem cell transplantation.
    Giménez E; Muñoz-Cobo B; Solano C; Amat P; de la Cámara R; Nieto J; López J; Remigia MJ; Garcia-Noblejas A; Navarro D
    Transpl Infect Dis; 2015 Jun; 17(3):361-70. PubMed ID: 25850900
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Kinetics of cytomegalovirus (CMV) pp65 and IE-1-specific IFNgamma CD8+ and CD4+ T cells during episodes of viral DNAemia in allogeneic stem cell transplant recipients: potential implications for the management of active CMV infection.
    Tormo N; Solano C; Benet I; Nieto J; de la Cámara R; Garcia-Noblejas A; Clari MA; Chilet M; López J; Hernández-Boluda JC; Remigia MJ; Navarro D
    J Med Virol; 2010 Jul; 82(7):1208-15. PubMed ID: 20513086
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Target structures of the CD8(+)-T-cell response to human cytomegalovirus: the 72-kilodalton major immediate-early protein revisited.
    Kern F; Surel IP; Faulhaber N; Frömmel C; Schneider-Mergener J; Schönemann C; Reinke P; Volk HD
    J Virol; 1999 Oct; 73(10):8179-84. PubMed ID: 10482568
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Human cytomegalovirus specific CD8(+) T lymphocytes display interferon-gamma secretion impairment in kidney transplant recipients with pp65 antigenemia.
    Yang R; Xia T; Xu G; Li Z; Ying Z; Xu X
    Transplant Proc; 2008 Dec; 40(10):3500-4. PubMed ID: 19100424
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Cytomegalovirus immune reconstitution occurs in recipients of allogeneic hematopoietic cell transplants irrespective of detectable cytomegalovirus infection.
    Gallez-Hawkins G; Thao L; Lacey SF; Martinez J; Li X; Franck AE; Lomeli NA; Longmate J; Diamond DJ; Spielberger R; Forman SJ; Zaia JA
    Biol Blood Marrow Transplant; 2005 Nov; 11(11):890-902. PubMed ID: 16275592
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Evaluation of human cytomegalovirus-specific CD8+ T-cells in allogeneic haematopoietic stem cell transplant recipients using pentamer and interferon-γ-enzyme-linked immunospot assays.
    Liu A; Ma Y; Wu W; Chen X; Huang Y; Hu J; Liang H; Wang H; Yang R; Fan J
    J Clin Virol; 2013 Oct; 58(2):427-31. PubMed ID: 23910932
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Lack of prompt expansion of cytomegalovirus pp65 and IE-1-specific IFNgamma CD8+ and CD4+ T cells is associated with rising levels of pp65 antigenemia and DNAemia during pre-emptive therapy in allogeneic hematopoietic stem cell transplant recipients.
    Tormo N; Solano C; Benet I; Clari MA; Nieto J; de la Cámara R; López J; López-Aldeguer N; Hernández-Boluda JC; Remigia MJ; Garcia-Noblejas A; Gimeno C; Navarro D
    Bone Marrow Transplant; 2010 Mar; 45(3):543-9. PubMed ID: 19617905
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Clinical factors influencing phenotype of HCMV-specific CD8+ T cells and HCMV-induced interferon-gamma production after allogeneic stem cells transplantation.
    Gayoso I; Cantisán S; Cerrato C; Sánchez-García J; Martin C; Solana R; Torres-Gomez A; Torre-Cisneros J
    Clin Dev Immunol; 2013; 2013():347213. PubMed ID: 23424600
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Reconstitution of CMV pp65 and IE-1-specific IFN-γ CD8(+) and CD4(+) T-cell responses affording protection from CMV DNAemia following allogeneic hematopoietic SCT.
    Tormo N; Solano C; Benet I; Nieto J; de la Cámara R; López J; Garcia-Noblejas A; Muñoz-Cobo B; Costa E; Clari MA; Hernández-Boluda JC; Remigia MJ; Navarro D
    Bone Marrow Transplant; 2011 Nov; 46(11):1437-43. PubMed ID: 21243030
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Late diversification in the clonal composition of human cytomegalovirus-specific CD8+ T cells following allogeneic hemopoietic stem cell transplantation.
    Gandhi MK; Wills MR; Okecha G; Day EK; Hicks R; Marcus RE; Sissons JG; Carmichael AJ
    Blood; 2003 Nov; 102(9):3427-38. PubMed ID: 12869514
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.